Related Experiment Video
Updated: Jan 10, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Optimal adjuvant radiotherapy strategy for cervical cancer: a multi-center database cohort study
Fang Bai1, Guangzhe Wu1, Xinyu Qu2
1Fudan University Shanghai Cancer Center, Department of Gynecologic Oncology, Shanghai, China; Fudan University, Shanghai Medical College, Department of Oncology, Shanghai, China.
Concurrent chemoradiation offers superior progression-free survival for high-risk cervical cancer patients. For intermediate-risk patients, standard radiation therapy or concurrent chemoradiation show similar outcomes, suggesting tailored treatment strategies are key.
Area of Science:
- Gynecologic Oncology
- Radiation Oncology
- Clinical Research
Background:
- Post-operative radiotherapy patterns significantly influence cervical cancer prognosis.
- Optimal adjuvant treatment strategies are crucial for improving patient outcomes in early-stage cervical cancer.
- Identifying risk-stratified treatment approaches is essential for personalized care.
Purpose of the Study:
- To evaluate the prognostic impact of different post-operative radiotherapy modalities in cervical cancer.
- To identify an optimal treatment strategy based on patient risk stratification.
- To compare adjuvant radiation therapy, concurrent chemoradiation, and sequential chemoradiotherapy outcomes.
Main Methods:
- A multi-center cohort study utilizing the Standardized Cervical Cancer-Specific Database.
- Inclusion of patients with International Federation of Gynecology and Obstetrics stage IB1-IIA2 undergoing radical hysterectomy and adjuvant treatment.
- Stratification into high-risk and intermediate-risk groups, with Kaplan-Meier, Cox regression, and propensity score matching analyses.
Main Results:
- Concurrent chemoradiation demonstrated superior 3-year progression-free survival in high-risk patients compared to sequential chemoradiotherapy and radiation therapy.
- For intermediate-risk patients, both radiation therapy and concurrent chemoradiation showed better progression-free survival than sequential chemoradiotherapy.
- Post-matching analyses confirmed concurrent chemoradiation's benefit in high-risk patients, with no significant differences between radiation therapy and concurrent chemoradiation in intermediate-risk patients.
Conclusions:
- Concurrent chemoradiation is a preferred approach for high-risk cervical cancer patients.
- Adjuvant chemotherapy added to radiation therapy did not improve prognosis for intermediate-risk patients.
- Risk-stratified treatment selection is vital for optimizing outcomes in cervical cancer management.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024